RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 78 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $186,000 | -88.4% | 217,621 | -25.4% | 0.00% | – |
| Q1 2022 | $1,609,000 | -45.5% | 291,877 | -4.4% | 0.00% | -100.0% |
| Q4 2021 | $2,955,000 | -44.8% | 305,266 | +2.1% | 0.00% | -50.0% |
| Q3 2021 | $5,349,000 | -28.4% | 299,122 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $7,471,000 | +3.3% | 306,047 | +12.2% | 0.00% | -33.3% |
| Q1 2021 | $7,229,000 | +292.0% | 272,791 | +12.3% | 0.00% | +200.0% |
| Q4 2020 | $1,844,000 | +56.1% | 242,925 | +3.1% | 0.00% | 0.0% |
| Q3 2020 | $1,181,000 | -14.4% | 235,622 | +2.2% | 0.00% | 0.0% |
| Q2 2020 | $1,380,000 | +45.3% | 230,655 | +8.1% | 0.00% | 0.0% |
| Q1 2020 | $950,000 | -52.5% | 213,436 | +1.4% | 0.00% | 0.0% |
| Q4 2019 | $2,000,000 | +23.1% | 210,493 | +1.7% | 0.00% | 0.0% |
| Q3 2019 | $1,625,000 | -11.2% | 206,994 | +78.1% | 0.00% | 0.0% |
| Q2 2019 | $1,829,000 | -3.5% | 116,221 | +11.0% | 0.00% | 0.0% |
| Q1 2019 | $1,896,000 | +90.4% | 104,715 | +69.1% | 0.00% | 0.0% |
| Q4 2018 | $996,000 | -33.8% | 61,913 | -1.2% | 0.00% | 0.0% |
| Q3 2018 | $1,504,000 | – | 62,653 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |